Q2 EPS Estimate for Astria Therapeutics Decreased by Analyst
Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) – Equities research analysts at HC Wainwright lowered their Q2 2025 earnings estimates for shares of Astria Therapeutics in a report released on Wednesday, May 14th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of ($0.67) per share for the quarter, down […]
Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) – Equities research analysts at HC Wainwright lowered their Q2 2025 earnings estimates for shares of Astria Therapeutics in a report released on Wednesday, May 14th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of ($0.67) per share for the quarter, down […]
